These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Platelet function studies in myeloproliferative disorders. Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631 [TBL] [Abstract][Full Text] [Related]
16. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis]. Hochhaus A; Mindner K; Ostermann G; Höche D Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878 [TBL] [Abstract][Full Text] [Related]
17. [Platelet factor 3 activity in myeloproliferative disorders as evaluation by a new simple method]. Inceman S; Tangün Y Turk Tip Cemiy Mecm; 1970; 36(9):317-20. PubMed ID: 5524541 [No Abstract] [Full Text] [Related]
18. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Yamamoto K; Sekiguchi E; Takatani O Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753 [TBL] [Abstract][Full Text] [Related]
19. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts? Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056 [TBL] [Abstract][Full Text] [Related]
20. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome]. Zuk E Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]